- Home
- SBSI vs YDES Comparison
SBSI vs YDES Comparison
Compare SBSI & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SBSI | YDES |
|---|---|---|
| Founded | 1960 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 936.3M | 894.2M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | SBSI | YDES |
|---|---|---|
| Price | $30.58 | $8.15 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.50 | N/A |
| AVG Volume (30 Days) | ★ 95.0K | 15.4K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.29 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.87 | N/A |
| Revenue Next Year | $5.82 | N/A |
| P/E Ratio | $13.68 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.85 | $7.90 |
| 52 Week High | $34.37 | $25.00 |
Technical Indicators
Market Signals| Indicator | SBSI | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 34.49 | 33.77 |
| Support Level | $27.73 | $8.12 |
| Resistance Level | $31.60 | $9.46 |
| Average True Range (ATR) | 0.79 | 0.64 |
| MACD | -0.21 | 0.03 |
| Stochastic Oscillator | 14.02 | 7.32 |
Price Performance
Historical ComparisonAbout SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.